Tomás Chivato
Universidad San Pablo CEU(ES)
Publications by Year
Research Areas
Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Respiratory and Cough-Related Research, Parasite Biology and Host Interactions
Most-Cited Works
- → Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma(2020)385 cited
- → Sub-Lingual Immunotherapy(2009)247 cited
- → Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper(2023)222 cited
- → Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement(2020)167 cited
- → Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma(2020)135 cited
- → Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines(2021)123 cited
- → Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives(2021)113 cited
- → COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper(2020)110 cited
- → Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma(2020)88 cited
- → ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – An EAACI‐ARIA Position Paper(2020)83 cited